IMUX – immunic, inc. (US:NASDAQ)

News

Immunic to Participate in Investor Conferences in March
Immunic (IMUX) had its price target lowered by HC Wainwright from $8.00 to $5.00. They now have a "buy" rating on the stock.
Immunic secures $400M to support late-stage MS trials - ICYMI [Yahoo! Finance]
Immunic sets stage for phase 3 MS data readout after $400M financing [Yahoo! Finance]
Immunic, Inc. Reports Year-End 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com